Cargando…
Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
BACKGROUND: Essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF) are clonal hematological diseases classified as Philadelphia chromosome-negative myeloproliferative neoplasms (MPN). MPN pathogenesis is associated with the presence of somatic driver mutations, bone...
Autores principales: | Cominal, Juçara Gastaldi, Cacemiro, Maira da Costa, Berzoti-Coelho, Maria Gabriela, Pereira, Illy Enne Gomes, Frantz, Fabiani Gai, Souto, Elizabeth Xisto, Covas, Dimas Tadeu, de Figueiredo-Pontes, Lorena Lobo, Oliveira, Maria Carolina, Malmegrim, Kelen Cristina Ribeiro, de Castro, Fabíola Attié |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167065/ https://www.ncbi.nlm.nih.gov/pubmed/34084749 http://dx.doi.org/10.3389/fonc.2021.665037 |
Ejemplares similares
-
Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
por: Cacemiro, Maira da Costa, et al.
Publicado: (2018) -
Erratum on “Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation”
por: Cacemiro, Maira da Costa, et al.
Publicado: (2021) -
Emerging Role of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Pathogenesis of Haematological Malignancies
por: Cominal, Juçara Gastaldi, et al.
Publicado: (2019) -
Differential cytokine network profile in polycythemia vera and secondary polycythemia
por: Cacemiro, Maira da Costa, et al.
Publicado: (2020) -
Correction to: Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies
por: Noronha, Nádia de Cássia, et al.
Publicado: (2019)